Plain-English translation of NCT06781437 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that reviews medical records from lymphoma patients who were diagnosed and treated between 1980 and 2021 at a major Italian hospital. Researchers want to learn from your past medical information — including what treatments you received, how well they worked, and any side effects you experienced — to help improve care for future lymphoma patients.
Lymphoma is a complex disease with many different types and treatment options. By studying real patient experiences and outcomes over decades, researchers can better understand which factors predict how well someone will respond to treatment, how lifestyle and work environment may play a role, and which treatments work best — knowledge that will help doctors make better decisions for patients in the future.
You likely qualify if…
You likely don't qualify if…
This is not a treatment study, so you won't take any new medications or undergo new procedures. Instead, researchers will review your existing medical records from your lymphoma care — including your diagnosis, treatments received, how you responded, any side effects, and how you're doing now. The study team will gather this information one time from your medical history. No additional visits or tests are required.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Italy
Enrollment target
~5,500 participants
Started
February 2022
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pier Luigi Zinzani, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.